Prevalence of human papillomavirus in cancer of the oropharynx by gender

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 12, 2014, Pages 2954-2958

  Combes, Jean Damien ^a   Chen, Alyce A ^a   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P16; VIRUS DNA;

ARTICLE; AUSTRALIA; CANADA; CANCER RISK; CZECH REPUBLIC; FEMALE; FRANCE; GERMANY; HUMAN; IN SITU HYBRIDIZATION; JAPAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NORWAY; OROPHARYNX CANCER; POLYMERASE CHAIN REACTION; SMOKING HABIT; SWEDEN; TAIWAN; UNITED KINGDOM; UNITED STATES; WART VIRUS; ADVERSE EFFECTS; GENDER IDENTITY; LUNG NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PREVALENCE; SMOKING; VIROLOGY;

FEMALE; GENDER IDENTITY; HUMANS; LUNG NEOPLASMS; MALE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SMOKING;

EID: 84908590734     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0580     Document Type: Article

References (11)

1. de Martel C., Ferlay J, Franceschi S., Vignat J, Bray F, Forman D., et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-15.
2. Mehanna H, Beech T, Nicholson T., El-Hariry I, McConkey C, Paleri V., et al. Prevalence of human papillomavirus in oropharyngeal and non-oropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2013; 35: 747-55.
3. Franceschi S, Bidoli E, Herrero R., Muñoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 2000; 36: 106-15.
4. Chaturvedi AK, Engels EA, Pfeiffer R.M., Hernandez BY, Xiao W, Kim E, et al Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-301.
5. Gillison ML, Broutian T, Pickard R.K., Tong ZY, Xiao W, Kahle L, et al Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307: 693-703.
6. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado M.P., Ferlay J., Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013; 31: 4550-9.
7. Ferlay J, Soerjomataram I, Ervik M., Dikshit R, Eser S, Mathers C., et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase no. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
8. IARC. Monographs on the evaluation of carcinogenic risks to humans Volume 85: betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. Lyon: International Agency for Research on Cancer; 2004.
9. Hernandez BY, Wilkens LR, Zhu X, Thompson P., McDuffie K, Shvetsov YB, et al Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008; 14: 888-94.
10. Kreimer AR, Bhatia RK, Messeguer A.L., Gonzalez P., Herrero R, Giuliano AR, et al Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010; 37: 386-91.
11. Combes JD, Franceschi S. Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 2014; 50: 370-9.